Ranjit Shahani

Rediff.com » News » Ranjit Shahani

News for Ranjit Shahani

Business

After 15 years, Ranjit Shahani steps down as Novartis' India chief

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in......

Why price cap on drugs is counter productive

To ensure equal access to health care, the government must consider it in a holistic manner and improve all parameters, says Ranjit Shahani. India is the fourth fastest growing economy in......

Novartis has 219 patents in India

India’s intent to respect intellectual property may have drawn international criticism following the Supreme Court’s decision on Glivec, but facts point at a different story.After Swiss......

Indian pharma has no incentive to innovate

No one expected, when the first major clinical trial started on Glivec in 2000, that the patients would live much beyond a couple of years.Yet, seven years later, 86 per cent of them were still......

SC decision on Novartis to benefit poor: Pharma cos

Poor patients will have easier access to quality medicines with the Supreme Court rejecting Swiss firm Novartis' patent plea for its cancer drug Glivec, according to domestic......

Rediff News

Ranjit Shahani

News for Ranjit Shahani

After 15 years, Ranjit Shahani steps down as Novartis' India chief

Why price cap on drugs is counter productive

Novartis has 219 patents in India

Indian pharma has no incentive to innovate

SC decision on Novartis to benefit poor: Pharma cos

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS